Xylocaine Injection, Solution
Product Images NDC 0404-9972

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 0404-9972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Lidocaine Hydrochloride, showing its molecular components including aromatic rings, amine groups, and hydrochloride salt.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram showing a molecular structure with a benzene ring having two hydroxyl (OH) groups attached and an adjacent carbon attached to a CH2NHCH3 group. This depicts the chemical structure of the active ingredient, consistent with Lidocaine Hydrochloride.*

FDA Label Image

Image1.jpg (Image1)

A table listing drug classes in the left column and examples in the right column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples for Local anesthetics include lidocaine and related compounds.*

FDA Label Image

Image2.jpg (Image2)

A dosage guide table for Xylocaine (lidocaine hydrochloride) injection without epinephrine. It details recommended concentrations (%), volume ranges (mL), and total dosage (mg) for various procedures including infiltration (percutaneous and intravenous regional), peripheral nerve blocks (brachial, dental, intercostal, paravertebral, pudendal), paracervical obstetrical analgesia, sympathetic nerve blocks (cervical, lumbar), and central neural blocks (epidural thoracic and lumbar, caudal obstetrical analgesia and surgical anesthesia).*

FDA Label Image

Image3.jpg (Image3)

A data table listing Xylocaine (lidocaine HCl injection, USP) product codes, NDC units of sale, strengths ranging from 0.5% to 2%, and vial sizes including 10 mL, 20 mL, and 50 mL multiple dose vials. The table details specific NDC codes for each product configuration and package unit of 25.*

FDA Label Image

Image4.jpg (Image4)

A data table listing various product codes, unit sales, strengths, and packaging details for Xylocaine (lidocaine HCl injection, USP). The table includes multiple strengths ranging from 0.5% to 2%, with different vial and ampule sizes, unit quantities, and associated NDC codes.*

FDA Label Image

Image5.jpg (Image5)

The image displays two tables listing product codes, units of sale, strengths, and NDC numbers for Xylocaine (lidocaine HCl and epinephrine injection, USP) with epinephrine concentrations of 1:100,000 and 1:200,000. It includes multiple strengths ranging from 0.5% to 2% in various vial sizes (10 mL to 50 mL multiple dose vials).*

FDA Label Image

Image6.jpg (Image6)

A data table listing multiple product codes, units of sale, strengths, and corresponding NDC codes for Xylocaine-MPF (lidocaine HCl and epinephrine injection). It details strengths ranging from 1% to 2% in volumes of 10 mL, 20 mL, and 30 mL single dose vials, with unit sale quantities of 5 or 25.*

FDA Label Image

Label1.jpg (Label1)

Xylocaine MPF 2% Injection USP, a single dose vial containing lidocaine hydrochloride and epinephrine at 400 mg per 20 mL, labeled for infiltration and nerve block including caudal and epidural use. The label states it is methylparaben-free, sterile, and nonpyrogenic, filled under nitrogen. It includes storage instructions at 29 to 25°C and warnings about color changes, light protection, and keeping out of children's reach. Packaged by Henry Schein, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.